Chai Discovery logo

Chai Discovery

Develops AI systems for drug design, helping pharmaceutical partners discover and optimize therapeutic candidates.

AI Healthcare
Drug Discovery
Total Raised
$400M
Last Valuation
$3.3B
Headquarters
San Francisco, United States

Overview

Chai Discovery builds AI technology for drug design, targeting pharmaceutical and biotech organizations seeking faster ways to identify and develop therapeutic candidates. Its positioning is centered on applying advanced AI to discovery workflows. The company raised a $400 million Series C in July 2026, bringing total funding to $400 million. The round followed a Novartis deal and reportedly valued the OpenAI-backed company at $3.8 billion, tripling in seven months.

Funding History

1 round · Jul 2026
$400M
Total Raised
1
Valuation: $3.3B
Cumulative: $400M

Chai Discovery triples to $3.8B in 7 months as OpenAI-backed drug designer lands $400M after Novartis deal

Investors not disclosed
Source

Frequently Asked Questions

How much has Chai Discovery raised in total?
Chai Discovery has raised a total of $400M across 1 funding round.
What does Chai Discovery do?
Chai Discovery builds AI technology for drug design, targeting pharmaceutical and biotech organizations seeking faster ways to identify and develop therapeutic candidates. Its positioning is centered on applying advanced AI to discovery workflows. The company raised a $400 million Series C in July 2026, bringing total funding to $400 million. The round followed a Novartis deal and reportedly valued the OpenAI-backed company at $3.8 billion, tripling in seven months.
Where is Chai Discovery headquartered?
Chai Discovery is headquartered in San Francisco, United States.